BioSpace News Archive

Press Releases

Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones

July 16, 2024
·
7 min read
Press Releases

SFA Therapeutics Strengthens Management Team with Appointment of Chief Operating Officer

July 16, 2024
·
4 min read
Press Releases

The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello

July 16, 2024
·
8 min read
Press Releases

Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada

July 16, 2024
·
5 min read
Drug Development

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis (ALS)

July 16, 2024
·
4 min read
Drug Development

CSL Behring Announces Positive Reimbursement Decision in Canada for HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B

July 16, 2024
·
6 min read
News

SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems

July 16, 2024
·
2 min read
Press Releases

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

July 16, 2024
·
1 min read
Business

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

July 16, 2024
·
1 min read
Press Releases

Shineco Announces Closing of $2 Million Underwritten Public Offering

July 16, 2024
·
3 min read